This is a renewal application for the YRDRCC that was initially funded in August 2007. We focused our original application on two goals ~ bringing and disseminating new core technologies to investigators at Yale studying the rheumatic and immunological diseases and the inflammatory pathways that mediate their pathogenesis, and expanding the number of investigators and research base in these areas through these cores and an enrichment program. These goals were ambitious, particularly the former, in that we planned to build essentially from scratch two technologically sophisticated, research cores in the genesis and cryopreservation of genetically modified mice, and in in vivo imaging, rather than building upon existing infrastructure at the institution. We believe we have succeeded in these goals, developing and burnishing two highly productive research cores in the YRDRCC, offering novel technologies to a broad group of investigators, many of whom are new to rheumatic disease focused research, and we have used these cores and our enrichment activities to enhance collaborations in rheumatic and immunological diseases and to bring additional resources to Yale. We have also laid the groundwork for the next phase of the YRDRCC, outlined in this application, in which we intend to bring additional research technologies to Yale investigators, while offering an enrichment program that seeks to expand the use, and fruits, of these technologies by the broader national and international rheumatic and immunological research disease community. We still intend to serve as the Yale home for research into these illnesses, yet are determined over the next five years to expand the YRDRCC beyond Yale. The overall Goal of this renewal of the YRDRCC is to continue to foster a research environment dedicated to advancing our knowledge of the etiology, pathogenesis, and treatment of autoimmune and rheumatic diseases and the inflammatory pathways that mediate their pathogenesis. Toward this end, the Aims of the YRDRCC are to: 1) stimulate multidisciplinary collaborative investigation of the pathogenesis of the rheumatic diseases;2) to organize resources, techniques, and procedures into high quality, cost-efficient facilities used by multiple investigators, and to disseminate this technology and its fruits inside and outside th Yale community;and 3) to provide a rich educational environment that will encourage new and established investigators to study the rheumatic and immunological diseases, while providing them and investigators outside Yale, knowledge of advanced technological tools to carry forward such research.

Public Health Relevance

Coordination and integration of research and educational activities are critical to strengthening and expanding the study of rheumatic and immunological diseases and the inflammatory pathways that promote their pathogenesis. This Core Center will foster the continued development of research into these illnesses at Yale, and to broaden its impact beyond the borders of the institution.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAR1)
Program Officer
Mancini, Marie
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
Internal Medicine/Medicine
Schools of Medicine
New Haven
United States
Zip Code
Fistonich, Chris; Zehentmeier, Sandra; Bednarski, Jeffrey J et al. (2018) Cell circuits between B cell progenitors and IL-7+ mesenchymal progenitor cells control B cell development. J Exp Med 215:2586-2599
Gies, Vincent; Schickel, Jean-Nicolas; Jung, Sophie et al. (2018) Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus. JCI Insight 3:
Gonzalez, David G; Cote, Christine M; Patel, Jaymin R et al. (2018) Nonredundant Roles of IL-21 and IL-4 in the Phased Initiation of Germinal Center B Cells and Subsequent Self-Renewal Transitions. J Immunol 201:3569-3579
Manfredo Vieira, S; Hiltensperger, M; Kumar, V et al. (2018) Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 359:1156-1161
Greiling, Teri M; Dehner, Carina; Chen, Xinguo et al. (2018) Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med 10:
Kim, Sang Taek; Choi, Jin-Young; Lainez, Begona et al. (2018) Human Extrafollicular CD4+ Th Cells Help Memory B Cells Produce Igs. J Immunol 201:1359-1372
Weinstein, Jason S; Laidlaw, Brian J; Lu, Yisi et al. (2018) STAT4 and T-bet control follicular helper T cell development in viral infections. J Exp Med 215:337-355
Ip, W K Eddie; Hoshi, Namiko; Shouval, Dror S et al. (2017) Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science 356:513-519
Swartz, Kelsey L; Wood, Scott N; Murthy, Tushar et al. (2017) E2F-2 Promotes Nuclear Condensation and Enucleation of Terminally Differentiated Erythroblasts. Mol Cell Biol 37:
Di Pietro, Caterina; Zhang, Ping-Xia; O'Rourke, Timothy K et al. (2017) Ezrin links CFTR to TLR4 signaling to orchestrate anti-bacterial immune response in macrophages. Sci Rep 7:10882

Showing the most recent 10 out of 88 publications